Cargando…

Preparation and Evaluation of (64)Cu-Radiolabled Dual-Ligand Multifunctional Gold Nanoparticles for Tumor Theragnosis

Gold nanoparticles (AuNPs) are cutting-edge platforms for combined diagnostic and therapeutic approaches due to their exquisite physicochemical and optical properties. Using the AuNPs physically produced by femtosecond pulsed laser ablation of bulk Au in deionized water, with a capping agent-free su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mhanna, Karim, Qian, Wei, Zhong, Ziyun, Brooks, Allen F., Ouchi, Erika, Stauff, Jenelle, Arteaga, Janna, Papachristou, Maria, Datseris, Ioannis E., Liu, Bing, Shao, Xia, Scott, Peter J. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863725/ https://www.ncbi.nlm.nih.gov/pubmed/36678568 http://dx.doi.org/10.3390/ph16010071

Ejemplares similares

State of the Art Biocompatible Gold Nanoparticles for Cancer Theragnosis
por: Kang, Moon Sung, et al.
Publicado: (2020)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

Near-Infrared Plasmonic Assemblies of Gold Nanoparticles with Multimodal Function for Targeted Cancer Theragnosis
por: Kim, Seong-Eun, et al.
Publicado: (2017)

Reveal: Fluorescence Enhanced Theragnosis by Designs for Vision
por: Steier, Liviu
Publicado: (2020)

Synthesis and Evaluation of a Fluorine-18 Radioligand for Imaging Huntingtin Aggregates by Positron Emission Tomographic Imaging
por: Kaur, Tanpreet, et al.
Publicado: (2021)

Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET
por: Brooks, Allen F., et al.
Publicado: (2022)

Synthesis and Initial In Vivo Evaluation of [(11)C]AZ683—A Novel PET Radiotracer for Colony Stimulating Factor 1 Receptor (CSF1R)
por: Tanzey, Sean S., et al.
Publicado: (2018)

Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis
por: Das, Sabya Sachi, et al.
Publicado: (2020)

Nanotechnology: A Promising Approach for Cancer Diagnosis, Therapeutics and Theragnosis
por: Dessale, Mesfin, et al.
Publicado: (2022)

CuGeO(3) Nanoparticles: An Efficient Photothermal Theragnosis Agent for CT Imaging-Guided Photothermal Therapy of Cancers
por: Wang, Jiawu, et al.
Publicado: (2020)

Circulating MicroRNAs as Minimally Invasive Biomarkers for Cancer Theragnosis and Prognosis
por: Cho, William C. S.
Publicado: (2011)

A Scalable Method for Squalenoylation and Assembly of Multifunctional (64)Cu-Labeled Squalenoylated Gemcitabine Nanoparticles
por: Tucci, Samantha T., et al.
Publicado: (2018)

Antimony-Doped Tin Oxide Nanocrystals for Enhanced Photothermal Theragnosis Therapy of Cancers
por: Lv, Zhongjing, et al.
Publicado: (2020)

Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE)
por: Drake, Lindsey R., et al.
Publicado: (2020)

Metal-chelating benzothiazole multifunctional compounds for the modulation and (64)Cu PET imaging of Aβ aggregation
por: Huang, Yiran, et al.
Publicado: (2020)

Towards Precision Oncology: Enhancing Cancer Screening, Diagnosis and Theragnosis Using Artificial Intelligence
por: Tran, William T.
Publicado: (2022)

2D Hetero-Nanoconstructs of Black Phosphorus for Breast Cancer Theragnosis: Technological Advancements
por: Soman, Soji, et al.
Publicado: (2022)

Radionuclide Cisternography with [(64)Cu]Cu-DOTA
por: Greiser, Julia, et al.
Publicado: (2023)

Benefits of Using Fluorescence Induced Theragnosis in Fixed Orthodontic Therapy: Status, Technology and Future Trends
por: Marya, Anand, et al.
Publicado: (2021)

Multifunctional gold nanostars for molecular imaging and cancer therapy
por: Liu, Yang, et al.
Publicado: (2015)

(64)Cu-ATSM/(64)Cu-Cl(2) and their relationship to hypoxia in glioblastoma: a preclinical study
por: Pérès, Elodie A., et al.
Publicado: (2019)

Comparison of the Effects of DOTA and NOTA Chelators on (64)Cu-Cudotadipep and (64)Cu-Cunotadipep for Prostate Cancer
por: Lee, Inki, et al.
Publicado: (2023)

Recent Advances in (64)Cu/(67)Cu-Based Radiopharmaceuticals
por: Krasnovskaya, Olga O., et al.
Publicado: (2023)

Novel Tumor-Targeted Self-Nanostructured and Compartmentalized Water-in-Oil-in-Water Polyurethane-Polyurea Nanocapsules for Cancer Theragnosis
por: Bonelli, Joaquín, et al.
Publicado: (2022)

(64)Cu-based Radiopharmaceuticals in Molecular Imaging
por: Zhou, Yeye, et al.
Publicado: (2019)

The Effects of Intramuscular Naloxone Dose on Mu Receptor Displacement of Carfentanil in Rhesus Monkeys
por: Scott, Peter J. H., et al.
Publicado: (2020)

Chelator-Free (64)Cu-Integrated Gold Nanomaterials for Positron Emission Tomography Imaging Guided Photothermal Cancer Therapy
por: Sun, Xiaolian, et al.
Publicado: (2014)

Synthesis and evaluation of (64)Cu-radiolabeled NOTA-cetuximab ((64)Cu-NOTA-C225) for immuno-PET imaging of EGFR expression
por: Xu, Xiaoxia, et al.
Publicado: (2019)

Harnessing (64)Cu/(67)Cu for a theranostic approach to pretargeted radioimmunotherapy
por: Keinänen, Outi, et al.
Publicado: (2020)

Theragnostic (64)Cu/(67)Cu Radioisotopes Production With RFT-30 Cyclotron
por: Lee, Jun Young, et al.
Publicado: (2022)

[(64)Cu]Cu-DOTATATE PET metrics in the investigation of atherosclerotic inflammation in humans
por: Jensen, Jacob K., et al.
Publicado: (2022)

Chitosan-based intelligent theragnosis nanocomposites enable pH-sensitive drug release with MR-guided imaging for cancer therapy
por: Lim, Eun-Kyung, et al.
Publicado: (2013)

Prevention and Management of Hormonal Crisis during Theragnosis with LU-DOTA-TATE in Neuroendocrine Tumors. A Systematic Review and Approach Proposal
por: del Olmo-García, Maria Isabel, et al.
Publicado: (2020)

In Response to the Article “Usefulness of Ultrasound Examinations in the Diagnostics of Necrotizing Enterocolitis”. Pol J Radiol, 2015; 80: 1–9
por: Mistry, Kewal A., et al.
Publicado: (2015)

(64)Cu-ATSM and (18)FDG PET uptake and (64)Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistry
por: Hansen, Anders E, et al.
Publicado: (2012)

The somatostatin receptor 2 antagonist (64)Cu-NODAGA-JR11 outperforms (64)Cu-DOTA-TATE in a mouse xenograft model
por: Rylova, Svetlana N., et al.
Publicado: (2018)

In Response to the Article “Joubert Syndrome Imaging Features and Illustration of a Case”; Pol J Radiol, 2015; 80: 381–83
por: Mistry, Kewal Arunkumar, et al.
Publicado: (2015)

Corrigendum “Imaging features of the lungs hydatid cyst disseminated into the brain and spleen”. [Radiol Case Rep 2019;14:903–5]
por: Yaghoobi, Mojtaba Hedayat, et al.
Publicado: (2023)

Effect of intratumoral administration on biodistribution of (64)Cu-labeled nanoshells
por: Xie, Huan, et al.
Publicado: (2012)

Integrated (64)Cu therapy for the peritoneal dissemination of gastrointestinal cancer
por: Kurihara, Hiroaki
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_38b6jdiane65qtq2mgk0kgr0du